michael uhrin

Smith & Nephew is a diversified advanced medical technology business. We support healthcare professionals in more than 100 countries to improve the quality of life for their patients.Since 1856, when our founder T.J. Smith developed a new method for refining cod liver oil, and in World War One when his nephew led the supply of wound care products, to the present day, Smith & Nephew continues to pioneer health solutions. Through our leadership positions in Sports Medicine, Trauma, Orthopaedic Reconstruction and Advanced Wound Management, our 15,000 employees continue to improve outcomes and expand access, constantly striving to create value for healthcare professionals, patients, payers and shareholders.Annual sales in 2015 were more than $4.6 billionWe are a constituent of the UK's FTSE100 and our shares are traded on London Stock Exchange and through American Depository Receipts on the New York Stock Exchange (LSE: SN,NYSE:SNN).